Membrane anchored and lipid raft targeted β-secretase inhibitors for alzheimer's disease therapy

Journal of Alzheimer's Disease

Volumn 24, Issue SUPPL. 2, 2011, Pages 143-152

  Halima, Saoussen Ben ^a   Rajendran, Lawrence ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Alzheimer's disease; amyloid; BACE1; drug design; endocytosis; inhibitor; lipid rafts; membrane anchoring; targeting; secretase

Indexed keywords

BETA SECRETASE 1; BETA SECRETASE 2; BETA SECRETASE INHIBITOR; CHOLESTANOL; CHOLESTEROL; ERGOSTEROL; SPHINGOLIPID; STIGMASTEROL;

ALZHEIMER DISEASE; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; INTRACELLULAR MEMBRANE; LIPID RAFT; NONHUMAN; PH; PRIORITY JOURNAL; REVIEW;

EID: 79955665531     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2011-110269     Document Type: Review

References (65)

1. De Strooper B (2010) Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol Rev 90, 465-494.
2. Roberson ED, Mucke L (2006) 100 years and counting: prospects for defeating Alzheimer's disease. Science 314, 781-784. (Pubitemid 44706637)
3. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112. (Pubitemid 46432529)
4. Steiner H (2004) Uncovering gamma-secretase. Curr Alzheimer Res 1, 175-181.
5. Kimberly WT, Zheng JB, Guenette SY, Selkoe DJ (2001) The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J Biol Chem 276, 40288-40292.
6. Haass C (2004) Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide genera-tion. EMBO J 23, 483-488. (Pubitemid 38282380)
7. Jorissen E, Prox J, Bernreuther C, Weber S, Schwanbeck R, Serneels L, Snellinx A, Craessaerts K, Thathiah A, Tesseur I, Bartsch U, Weskamp G, Blobel CP, Glatzel M, de Strooper B, Saftig P (2010) The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J Neu-rosci 30, 4833-4844.
8. Kuhn PH, Wang H, Dislich B, Colombo A, Zeitschel U, Ell-wart JW, Kremmer E, Rossner S, Lichtenthaler SF (2010) ADAM10 is the physiologically relevant, constitutive alpha-secretase ofthe amyloid precursor protein in primary neurons. EMBO J 29, 3020-3032.
9. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran, Burgess T, Louis J C, Collins F, Treanor J, Rogers G, Citron M (1999) Beta-secretase cleavage of Alzheimer's amy-loid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
10. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashier JR, Stratman NC, Mathews WR, Buhl AE, Carter DB, Tomasselli AG, Parodi LA, Heinrikson RL, Gurney ME (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533-537.
11. Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS, Murphy KE, Southan CD, Ryan DM, Smith TS, Simmons DL, Walsh FS, Dingwall C, Christie G (1999) Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci 14, 419-427. (Pubitemid 30026585)
12. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, Jacobson-Croak K, Jewett N, Keim P, Knops J, Lieberburg I, Power M, Tan H, Tatsuno G, Tung J, Schenk D, Seubert P, Suomen-saari SM, Wang S, Walker D, John V (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537-540.
13. Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J (2000) Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci USA 97, 1456-1460. (Pubitemid 30118462)
14. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 4, 233-234. (Pubitemid 32194867)
15. Citron M, Teplow DB, Selkoe DJ (1995) Generation of amyloid beta protein from its precursor is sequence specific. Neuron 14, 661-670.
16. Kao SC, Krichevsky AM, Kosik KS Tsai LH (2004) BACE1 suppression by RNA interference in primary cortical neurons. J Biol Chem 279, 1942-1949. (Pubitemid 38084465)
17. Vassar R (2002) Beta-secretase (BACE) as a drug target for Alzheimer's disease. Adv Drug Deliv Rev 54, 1589-1602. (Pubitemid 35346833)
18. Marcinkiewicz M, Seidah NG (2000) Coordinated expression of beta-amyloid precursor protein and the putative betasecretase BACE and alpha-secretase ADAM10 in mouse and human brain, J Neurochem 75, 2133-2143.
19. Kalvodova L, Kahya N, Schwille P, Ehehalt R, Verkade P, Drechsel D, Simons K (2005) Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J Biol Chem 280, 36815-36823. (Pubitemid 41587762)
20. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, Fan W, Kha H, Zhang J, Gong Y, Martin L, Louis JC, Yan Q, Richards WG, Citron M, Vassar R (2001) Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phe-notype and abolished beta-amyloid generation. Nat Neurosci 4, 231-232. (Pubitemid 32194866)
21. McConlogue L, Buttini M, Anderson JP, Brigham EF, Chen KS, Freedman SB, Games D, Johnson-Wood K, Lee M, Zeller M, Liu W, Motter R, Sinha S (2007). Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synap-tic pathology in APP Transgenic Mice. J Biol Chem 282, 26326-26334. (Pubitemid 47443774)
22. Capell A, Steiner H, Romig H, Keck S, Baader M, Grim MG, Baumeister R, Haass C (2000a) Presenilin-1 differen-tially facilitates endoproteolysis ofthe beta-amyloid precursor protein and Notch. Nat Cell Biol 2, 205-211.
23. Capell A, Steiner H, Willem M, Kaiser H, Meyer C, Wal-ter J, Lammich S, Multhaup G, Haass C (2000b) Maturation and pro-peptide cleavage of beta-secretase. J Biol Chem 275, 30849-30854.
24. Vetrivel KS, Thinakaran G (2010) Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim Bio-phys Acta 1801, 860-867.
25. Vetrivel KS, Meckler X, Chen Y, Nguyen PD, Seidah NG, Vassar R, Wong PC, Fukata M, Kounnas MZ, Thinakaran G (2009) Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts. JBiol Chem 284, 3793-3803.
26. Rajendran L, Schneider A, Schlechtingen G, Weidlich S, Ries J, Braxmeier T, Schwille P, Schulz JB, Schroeder C, Simons M, Jennings G, Knolker HJ, Simons K (2008) Efficient inhi-bition ofthe Alzheimer's disease beta-secretase by membrane targeting. Science 320, 520-523. (Pubitemid 351590663)
27. Ehehalt R, Keller P, Haass C, Thiele C, Simons K (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160, 113-123. (Pubitemid 36091721)
28. Koo EH, Squazzo SL (1994) Evidence that production and release of amyloid beta-protein involves the endocytic path-way. J Biol Chem 269, 17386-17389. (Pubitemid 24218009)
29. Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, Simons K (2006) Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci USA 103, 11172-11177. (Pubitemid 44156491)
30. Schneider A, Rajendran L, Honsho M, Gralle M, Donnert G, Wouters F, Hell SW, Simons M. Flotillin-dependent clustering of the amyloid precursor protein regulates its endocytosis and amyloidogenic processing in neurons. J Neurosci 28, 2874-2882.
31. Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk D, Lannfelt L, Selkoe DJ (1995) The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat Med 1, 1291-1296.
32. Thinakaran G, Teplow DB, Siman R, Greenberg B, Sisodia SS (1996) Metabolism of the "Swedish" amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the "beta-secretase" site occurs in the golgi apparatus. JBiol Chem 271, 9390-9397.
33. Goldsbury C, Mocanu MM, Thies E, Kaether C, Haass C, Keller P, Biernat J, Mandelkow E, Mandelkow EM (2006) Inhibition of APP trafficking by tau protein does not increase the generation of amyloid-beta peptides. Traffic 7, 873-888. (Pubitemid 43871776)
34. Kaether C, Schmitt S, Willem M, Haass C (2006) Amyloid precursor protein and notch intracellular domains are gen-erated after transport of their precursors to the cell surface. Traffic 7, 408-415. (Pubitemid 43372750)
35. Gouras GK, Almeida CG, Takahashi RH (2005) Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 26, 1235-1244. (Pubitemid 41338539)
36. Rajendran L, Knobloch M, Geiger KD, Dienel S, Nitsch R, Simons K, Konietzko U (2007) Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes. Neurodegener Dis 4, 164-170. (Pubitemid 47000410)
37. Westmeyer GG, Willem M, Lichtenthaler SF, Lurman G, Multhaup G, Assfalg-Machleidt I, Reiss K, Saftig P, Haass C (2004) Dimerization of beta-site beta-amyloid precursor protein-cleaving enzyme. J Biol Chem 279, 53205-53212. (Pubitemid 40051823)
38. Tesco G, Koh YH, Kang EL, Cameron AN, Das S, Sena-Esteves M, Hiltunen M, Yang SH, Zhong Z, Shen Y, Simpkins JW, Tanzi RE (2007) Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 54, 721-737. (Pubitemid 46843521)
39. Cole SL, Vassar R (2009) Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1. Neu¬robiolAging30, 1535-1544.
40. Mitterreiter S, Page RM, Kamp F, Hopson J, Winkler E, Ha HR, Hamid R, Herms J, Mayer TU, Nelson DJ, Steiner H, Stahl T, Zeitschel U, Rossner S, Haass C, Lichtenthaler SF (2010) Bepridil and amiodarone simultaneously target the Alzheimer's disease beta-and gamma-secretase via distinct mechanisms. JNeurosci 30, 8974-8983.
41. Ghosh AK, Bilcer G, Harwood C, Kawahama R, Shin D, Hussain KA, Hong L, Loy JA, Nguyen C, Koelsch G, Ermolieff J, Tang J (2001) Structure-based design: potent inhibitors ofhuman brain memapsin 2 (beta-secretase). JMed Chem 44, 2865-2868. (Pubitemid 32879115)
42. Hong L, Koelsch G, Lin X, Wu S, Terzyan S, Ghosh AK, Zhang XC, Tang J (2000) Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Sci-ence 290, 150-153.
43. Willem M, Lammich S, Haass C (2009) Function, regulation and therapeutic properties of beta-secretase (BACE1). Semin Cell Dev Biol 20, 175-182.
44. Meredith JE Jr, Thompson LA, Toyn JH, Marcin L, Barten DM, Marcinkeviciene J, Kopcho L, Kim Y, Lin A, Guss V, Burton C, Iben L, Polson C, Cantone J, Ford M, Drexler D, Fiedler T, Lentz KA, Grace JE Jr, Kolb J, Corsa J, Pierdomenico M, Jones K, Olson RE, Macor JE, Albright CF (2008) P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice. J Pharmacol Exp Ther 326, 502-513.
45. Bennett BD, Babu-Khan S, Loeloff R, Louis JC, Curran E, Citron M, Vassar R (2000) Expression analysis of BACE2 in brain andperipheraltissues. J Biol Chem275, 20647-20651. (Pubitemid 30457651)
46. Simons K, Ikonen E (1997) Functional rafts in cell mem-branes. Nature 387, 569-572.
47. Lingwood D, Simons K (2010) Lipid rafts as a membrane-organizing principle. Science 327, 46-50.
48. Simons K, Vaz WL (2004) Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 33, 269-295. (Pubitemid 38829961)
49. Rajendran L, Simons K (2005) Lipid rafts and membrane dynamics. J Cell Sci 118, 1099-1102. (Pubitemid 40528680)
50. Marguet D, Lenne PF, Rigneault H, He HT (2006) Dynamics in the plasma membrane: how to combine fluidity and order. EMBO J 25, 3446-3457. (Pubitemid 44264856)
51. Cheng H, Vetrivel KS, Gong P, Meckler X, Parent A, Thi-nakaran G (2007) Mechanisms of disease: new therapeutic strategies for Alzheimer's disease-targeting APP processing in lipid rafts. Nat Clin Pract Neurol 3, 374-382. (Pubitemid 47040327)
52. Cordy JM, Hussain I, Dingwall C, Hooper NM, Turner AJ (2003) Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc Natl Acad Sci USA 100, 11735-11740. (Pubitemid 37206004)
53. Cordy JM, Hooper NM, Turner AJ (2006) The involvement of lipid rafts in Alzheimer's disease. Mol Membr Biol 23, 111-122.
54. Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A, Dingwall C, de Strooper B, Dotti CG (2004) Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 167, 953-960. (Pubitemid 39628117)
55. Hayashi H, Kimura N, Yamaguchi H, Hasegawa K, Yokoseki T, Shibata M, Yamamoto N, Michikawa M, Yoshikawa Y, Terao K, Matsuzaki K, Lemere CA, Selkoe DJ, Naiki H, Yanagisawa K (2004) A seed for Alzheimer amyloid in the brain. J Neurosci 24, 4894-4902. (Pubitemid 38668215)
56. Zhou L, Chavez-Gutierrez L, Bockstael K, Sannerud R, Annaert W, May PC, Karran E, de Strooper B (2011) Inhibi-tion of beta-secretase in vivo via antibody binding to unique loops (D and F) of BACE1. JBiol Chem 286, 8677-8687.
57. Tung JS, Davis DL, Anderson JP, Walker DE, Mamo S, Jewett N, Hom RK, Sinha S, Thorsett ED, John V (2002) Design of substrate-based inhibitors ofhuman beta-secretase. J Med Chem 45, 259-262. (Pubitemid 34073445)
58. Capell A, Meyn L, Fluhrer R, Teplow DB, Walter J, Haass C (2002) Apical sorting of beta-secretase limits amyloid beta-peptide production. J Biol Chem 277, 5637-5643. (Pubitemid 34968618)
59. Schmidt B, Baumann S, Braun HA, Larbig G (2006) Inhibitors and modulators of beta-and gamma-secretase. Curr Top Med Chem 6, 377-392.
60. Hills ID, Vacca JP (2007) Progress toward a practical BACE-1 inhibitor. Curr Opin Drug Discov Devel 10, 383-391. (Pubitemid 47093121)
61. Ingallinella P, Bianchi E, Ladwa NA, Wang YJ, Hrin R, Veneziano M, Bonelli F, Ketas TJ, Moore JP, Miller MD, Pessi A (2009) Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency. Proc Natl Acad Sci USA 106, 5801-5806.
62. Schieb H, Weidlich S, Schlechtingen G, Linning P, Jennings G, Gruner M, Wiltfang J, Klafki HW, Knolker HJ (2010) Structural design, solid-phase synthesis and activity of membrane-anchored beta-secretase inhibitors on Abeta gen-eration from wild-type and Swedish-mutant APP Chemistry 16, 14412-14423.
63. Maxfield FR, McGraw TE (2004) Endocytic recycling. Nat Rev Mol Cell Biol 5, 121-132. (Pubitemid 38160255)
64. Mukherjee S, Soe TT, Maxfield FR (1999) Endocytic sorting of lipid analogues differing solely in the chemistry of their hydrophobic tails, J Cell Biol 144, 1271-1284. (Pubitemid 29157304)
65. Rajendran L, Knolker HJ, Simons K (2010) Subcellular tar-geting strategies for drug design and delivery. Nat Rev Drug Discov 9, 29-42.